Prime Medicine, Inc. Common Stock (PRME) is a publicly traded Healthcare sector company. As of July 8, 2026, PRME trades at $4.50 with a market cap of $720.66M and a P/E ratio of -3.18. PRME moved +11.15% today. Year to date, PRME is +15.99%; over the trailing twelve months it is +5.00%. Its 52-week range spans $1.11 to $6.94. Analyst consensus is strong buy with an average price target of $7.83. Rallies surfaces PRME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PRME shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.50 |
| Market Cap | $720.66M |
| P/E Ratio | -3.18 |
| EPS | $-1.25 |
| Dividend Yield | 0.80% |
| 52-Week High | $6.94 |
| 52-Week Low | $1.11 |
| Volume | 5.41M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.03M |
| Net Income | $-198.37M |
| Gross Margin | 0.00% |
8 analysts cover PRME: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.83.